However, Novos market cap is far lower, under $200 billion, having lost about $400 billion in value since its peak in mid-2024
A., Rosenstock, J., Boka, G
Key results The results were dose-dependent and remarkable at every level: 1mg: Approximately 8.7% weight loss 4mg: Approximately 17.1% weight loss 8mg: Approximately 22.8% weight loss 12mg: Approximately 24.2% weight loss Placebo: Approximately 2.1% weight loss The 24.2% weight loss at 12mg over 48 weeks was unprecedented
Convenient and affordable, without injections
Started prioritizing protein, added resistance training
These approaches remain largely experimental and should be discussed with a qualified healthcare provider